INTRODUCTION
Infectious diseases are a major cause of morbidity and mortality worldwide (WHO, 2004) . Pharmaceutical industries are interested in marine plants because of their rich and active molecules (Perez, 1997; Madhusudan et al., 2011) . Certainly, the therapeutic potential of certain active molecules is extremely promising, notably for an antimicrobial and antiviral use (Val et al., 2001; Nakajima et al., 2009) . Microorganisms have developed adaptation mechanisms against the action of antimicrobial drugs (AlHaj et al., 2009 ). This is a major concern and an urgent need for searching for new and safe antibacterial agents. Several studies have been investigated about the biological activities of algae extracts (Tringali, 1997) . Different active molecules from seaweeds showed the antimicrobial activities against the pathogens e.g., S. aureus or P. aeruginosa that commonly cause infection in the human (Selvin and Lipton, 2004) . This is intended the researcher to continued their research into searching of novel molecules from marine algae. Fucoidan a sulphated polysaccharides, isolated from different seaweed species have been extensively studied due to their varied biological activities like pharmacological activity i.e., antithrombotic, anti-inflammatory, blood lipids reducing effect, antioxidant, and anticomplementary properties, activity against hepatopathy, uropathy and renalpathy, gastric protective effects and therapeutic potential in surgery (Li et al., 2008) . Although manifold studies on the biological activities of fucoidans have been performed but an antibacterial effect of fucoidan has been poorly reported. In this background the present study was conducted to evaluate the antibacterial capability of fucoidan from Sargassum wightii against eight human bacterial pathogens.
MATERIALS AND METHODS

Isolation of fucoidan
The brown seaweed Sargassum wightii was collected from the Mandapam coast of Tamilnadu, India and it was identified by the seaweed expert Dr. M. Ganesan, CSMCRI, Mandapam. Then the collected seaweeds were washed well enough and dried at room temperature in shadow, pulverized in a blender and sieved. The extraction of fucoidan was performed as described by Yang et al. (2008) . Milled seaweed of about 20g was treated with a liter of ethanol and stirred with a mechanical stirrer for about 12 hours at room temperature in order to remove proteins and pigments. After washing with acetone, centrifugation is done at 1800×g for 10 min. Then the residue was left to dry at room temperature. After well drying a biomass, 5g was taken and extracted in 100ml of distilled water at 65°C with stirring for an hour. The extraction was done twice and the extracts were pooled. The combined extracts were centrifuged at 18500×g for 10 minutes and the supernatant was collected. Then the supernatant was mixed well with 1% CaCl2 and the solution was kept at 4°C for overnight to precipitate Alginic acid. The solution was then centrifuged at 18500×g for 10 minutes and the supernatant was collected. Ethanol (99%) was added into the supernatant in order to arrive upon the final ethanol concentration of 30% and the solution was placed at 4°C for 4 hours. Again the solution was centrifuged at 18500×g for 10 minutes and the supernatant was collected. Again ethanol (99%) was added into the supernatant in order to arrive upon the final ethanol concentration of 70% and the solution was placed at 4°C for overnight. The intact fucoidan was then obtained through filtration of the solution with a nylon membrane 0.45µm size. Fucoidan yield was estimated based on the dried biomass obtained after the treatment of the milled sample with 85% EtOH as a percentage of the algal dry weight (% dry weight).
Chemical analysis
Fucose was estimated by the phenol-sulphuric acid method by Dubois et al., (1956 ) using L-fucose as stand-
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ard. Sulfate content was determined according to the gelatin-barium method by Saito et al., (1990) using sodium sulfate as standard.
Antibacterial assays Bacterial culture
In this study, the clinical pathogens such as Escherichia coli, Klebsiella pneumoniae, Vibrio cholerae, Proteus proteus, Shigella sonnie, Pseudomonas aeruginosa, Salmonella typhi and Klebsiella sp., were obtained from the Rajah Muthiah Medical College, Annamalai University, Tamil Nadu, India. Collection were reconstituted in Muller-Hinton's broth, cultures were resuscitated under aerobic conditions at 37 • C and 200 rpm to reach exponential growth. The concentration (10 7 colony-forming units (CFU)/ml) was routinely estimated by spectrophotometric turbidity measurement at 600 nm on a spectrophotometer and by CFU counts on tryptic soy agar (TSA).
Screening of antibacterial activity
The antibacterial activity of fucoidan was performed by agar plate diffusion assay. Petri plates containing MullerHinton's agar medium was prepared in sterilized water. Then 0.1 ml of test organisms were taken from the stock broth and swabbed on agar medium by using sterilized buds. Then the wells 6mm made on the agar plates by using sterilized well cutter. Fucoidan 500µg/ml fucoidan was prepared; 500µg/ml of tetracycline was used as a positive control. Then it was added to the respective wells by using sterilized pipette. Then the plates were incubated at 37°C for 24 h. The antibacterial activity of the test fucoidan was observed through zone of inhibition (in mm) on the plates.
Determination of Minimum Inhibitory Concentrations
The minimum inhibitory concentration (MIC) was tested in the listed strains. Equal volumes of each bacterial strain culture, were applied to Muller-Hinton's broth (MHB) with different concentration of fucoidan in the test tubes ranging from 250, 125, 62.5, 31.25, 15.62, 7.81, 3 .90, 1.95 and 0.97µg/ml, respectively. Whereas, the control used for the study was prepared without fucoidan. These serially diluted cultures were then incubated at 37°C for 24 h. After the incubation period, turbidity was observed. MIC was defined as the lowest concentration of fucoidan that completely inhibited the visible growth of the test microorganisms.
Minimum bactericidal concentration
To determine minimum bactericidal concentration (MBC), aliquots of one loopful of the above serially diluted and incubated concentration were streaked individually on petridish containing Muller Hinton's agar and incubated at 37°C for 18h, the lowest concentration of fucoidan in the plate that shows no bacterial growth on agar plate represents the MBC value for fucoidan.
Brine shrimp toxicity assay
A brine shrimp (Artemia) bioassay was performed to assess the toxicity of the fucoidan. Brine shrimp (Artemia salina) eggs were hatched for 48 h in a conical flask containing 500 ml of filtered seawater. The flask was well aerated with the aid of an air pump and incubated at 27±1°C with constant illumination (2000 lux approx.) for 48h. After hatching, the active nauplii were collected for this assay. The fucoidan was dissolved in 1 ml of aerated seawater at various concentrations (10, 50, 250, 500 and 1000 μg/ml). An aliquot of each concentration (1 ml) was transferred, into the aerated seawater (9 ml). Ten nauplii were transferred to each tube. The control group was treated identically without the addition of fucoidan to the 10 ml of seawater. After 24 h the number of survivors was counted and the fatality was calculated in percentage. The lethal concentration of fucoidan was defined as that which caused 50% mortality of the nauplii (LC50). Tests were carried out in triplicate.
RESULTS AND DISCUSSION
Species of brown seaweed are well known to contain large amounts of cell-wall polysaccharide, fucoidan, which is not found in terrestrial plants (Asker et al., 2007) . Fucoidan has a substantial component of L-fucose and sulfate ester groups (Bilan et al., 2006) and has a wide range of pharmacological and biomedicinal properties (Guven et al., 1999) . Similarly, Berteau and Mulloy (2003) reported that the antimicrobial activity of the polysaccharides is related its chemical structure and ester sulfate groups. On the other hand, several species of brown seaweed that has a high sulfate content have been reported to show differences in antimicrobial activities (Adhikari et al., 2006; Asker et al., 2007) . In the present study, fucoidan was extracted from brown seaweed Sargassum wightii by the method proposed by Yang et al. (2008) using ethanol and the yield of fucoidan was observed at 4.24 ± 0.35%. The major chemical constituent of the fucoidan was observed. The extracted fucoidan contains 52.86 ± 0.64% of fucose and 29.26 ± 0.83% of sulphate. In the present investigation, the yield was close to the value of 6.2%, reported by Chattopadhyay et al., 2010 in brown seaweed Turbinaria conoids and also yield value of 1.1-4.8% of fucoidan was observed in some other brown seaweed (Bilan et al., 2006) . The chemical constituent of fucoidan from Sargassum wightii had analogous amounts of fucose (42-66%) with smaller amounts of sulphate (11.5-34.2%) in combination with other seaweeds (Nakajima et al., 2009; Rioux et al., 2007) . For the present study, antibacterial effect of fucoidan was performed against the human bacterial pathogens by agar well diffusion method. The result was displayed in Table 1 . The maximum activity 18.6 ± 0.32 mm was obtained for Vibrio cholera and the minimum activity 8.6 ± 0.26 mm was obtained for Salmonella typhi. The minimum inhibitory concentration and minimum bactericidal concentration of fucoidan was displayed in Table 1 . The order of sensitivity to MIC and MBC of fucoidan was found between the 31.25 to 250 µg /ml and 62.5 to 500 µg /ml to the respective pathogens. In the present study, considerable activity was observed to the bacterial pathogens as mentioned in Table 1 . Similarly, Chotigeat et al., 2004 reported that the crude fucoidan from Sargassum polycystum showed the activity at 12 mg/ml against the 
Staphylococcus aureus (10mm). Similarly, Pierre et al., (2011) also reported the antimicrobial effect sulfated galactan from Chaetomorpha aerea against the human bacterial pathogens such as Staphylococcus aureus, Salmonella enteretidis, P. aeruginosa, Enterococcus faecalis, Bacillus subtilis, Micrococcus luteus and Candida glabnata. It was suggested that the molecular mechanism of fucoidan on antibacterial activity is required to be further studied. However, this indicates that fucoidan possessed the inhibitory and bactericidal effect against the above mentioned human bacterial pathogens. Nowadays, the brine shrimp assay is considered as an excellent method for preliminary investigations of toxicity, to several bioactive molecules from various sources (Quignard et al., 2003) . Interestingly, Parra et al., (2001) reported that, the toxic effect of medicinal plants was positively correlated between the lethality to brine shrimp and the corresponding oral lethal dose in mice. Our results have revealed that fucoidan from Sargassum wightii had nontoxic effect against the brine shrimp (Artemia). In the brine shrimp toxicity test, no mortality was observed during the incubation period at various concentrations of fucoidan.
